Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 4Completed 2Active not recruiting 2Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Immunoblastic Lymphadenopathy 1

Interventions

Specimen Handling 8venetoclax 7Azacitidine 6Cyclophosphamide 5Biopsy 4fludarabine phosphate 3Tacrolimus 3Etoposide 3fludarabine 2Stem Cell Transplantation 2Mitoxantrone 2Melphalan 2Magnetic Resonance Spectroscopy 2Cytarabine 2vactosertib 1regorafenib 1prednylidene 1methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside Pt(II) 1iadademstat 1gilteritinib 1eltrombopag 1deltacortene 1decitabine and cedazuridine drug combination 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1brincidofovir 1beta-apocarotenoid-14',13'-dioxygenase 1azathiopurine 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Abatacept × Other hematologic neoplasm × Clear all
NCT07388563 2026-05-08

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Suspended
20 enrolled
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡